Stay updated with breaking news from Cellorigin Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with Qilu Pharma to develop,...
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy
Beijing BoomRay Pharma has completed a $43 million Series A funding to develop novel radionuclide drugs that integrate diagnosis and treatment. Read more here...
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy - read this article along with other careers information, tips and advice on BioSpace